有効成分の市場規模、シェア、成長分析：形態別、タイプ別、供給源別、流通別、最終用途産業別、地域別 - 産業予測、2025年～2032年

世界の有効成分市場規模は、2023年に2,374億7,000万米ドルと評価され、2024年の2,510億1,000万米ドルから2032年には3,911億米ドルに成長し、予測期間中（2025年～2032年）のCAGRは5.7％で成長する見通しです。

パーソナルケアと化粧品市場は、パーソナルグルーミングと化粧品に対する消費者の関心の高まり、可処分所得の増加と都市化によって大きな成長を遂げています。このようなスキンケア、ヘアケア、カラーコスメの有効成分に対する需要の高まりは、医薬品分野の進歩によって補完され、高品質の医薬品有効成分（API）を必要とする革新的な医薬品開発につながっています。さらに、2050年までに65歳以上の高齢者が16億人に達すると予測される世界人口の急速な高齢化は、加齢に関連した健康リスクとの関連から、効果的で安全な有効成分の需要を高めると予想されます。この人口動態の変化は、特にアフリカやラテンアメリカのような地域において、パーソナルケアやヘルスケア産業全体の有効成分市場をさらに強化すると思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 原材料の分析
• 顧客と購買基準の分析

有効成分市場規模：形態別& CAGR（2025-2032）

• 市場概要
• 固体
• 液体

有効成分市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 保湿剤
• 抗老化剤
• UVフィルター
• 角質除去剤
• 抗菌剤
• その他

有効成分市場規模：供給源別& CAGR（2025-2032）

• 市場概要
• 天然
• 合成

有効成分市場規模：流通別& CAGR（2025-2032）

• 市場概要
• オンライン
• オフライン

有効成分市場規模：最終用途産業別& CAGR（2025-2032）

• 市場概要
• パーソナルケア・化粧品
  • ヘアケア
  • スキンケア
  • その他
• 製薬
  • タブレット
  • クリーム
  • その他
• 農業
  • 殺虫剤
  • 除草剤
  • その他
• その他

有効成分市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Pfizer Inc.（USA）
• Novartis International AG（Switzerland）
• Sanofi S.A.（France）
• Boehringer Ingelheim GmbH（Germany）
• Bristol-Myers Squibb Company（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Eli Lilly and Company（USA）
• GlaxoSmithKline plc（UK）
• Merck & Co., Inc.（USA）
• AbbVie Inc.（USA）
• Sun Pharmaceutical Industries Ltd.（India）
• Dr. Reddy's Laboratories Ltd.（India）
• Aurobindo Pharma Ltd.（India）
• Cipla Ltd.（India）
• Lupin Limited（India）
• Mylan N.V.（USA）
• Sandoz International GmbH（Germany）
• Fresenius Kabi AG（Germany）
• Lonza Group AG（Switzerland）

結論と推奨事項

Global Active Ingredients Market size was valued at USD 237.47 billion in 2023 and is poised to grow from USD 251.01 billion in 2024 to USD 391.1 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The personal care and cosmetics market is experiencing significant growth, driven by rising consumer interest in personal grooming and cosmetics, as well as increasing disposable income and urbanization. This growing demand for active ingredients in skincare, hair care, and color cosmetics is complemented by advancements in the pharmaceutical sector, leading to innovative drug developments that require high-quality active pharmaceutical ingredients (APIs). Additionally, a rapidly aging global population, projected to reach 1.6 billion individuals aged 65 and older by 2050, is expected to heighten the demand for effective and safe active ingredients due to their association with age-related health risks. This demographic shift, particularly in regions like Africa and Latin America, will further bolster the active ingredients market across personal care and healthcare industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Active Ingredients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Active Ingredients Market Segmental Analysis

Global Active Ingredients Market is segmented by Form, Type, Source, Distribution, End-Use Industry and region. Based on Form, the market is segmented into Solid and Liquid. Based on Type, the market is segmented into Moisturizing Agents, Anti-ageing Agents, UV Filters, Exfoliating Agents, Antimicrobial Agents and Others. Based on Source, the market is segmented into Natural and Synthetic. Based on Distribution, the market is segmented into Online and Offline. Based on End-Use Industry, the market is segmented into Personal Care & Cosmetics, Pharmaceutical, Agriculture and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Active Ingredients Market

The Global Active Ingredients market is being propelled by a surge in consumer demand for functional nutrients, fueled by heightened awareness of the correlation between nutrition and overall health. As individuals increasingly seek out foods, beverages, and dietary supplements that offer enhanced nutritional value, the emphasis on active ingredients like vitamins, minerals, antioxidants, and plant extracts intensifies. Research into the health benefits of these components-particularly regarding immunity support, mental well-being, and anti-aging properties-further drives this trend. Consequently, the market is witnessing significant growth as consumers prioritize products that contribute to their health and wellness initiatives.

Restraints in the Global Active Ingredients Market

The Global Active Ingredients market faces significant restraints due to price fluctuations in emerging nations. Unpredictable and periodic alterations in drug pricing regulations within these regions, where many manufacturing companies are based, are likely to hinder market expansion during the forecast period. Additionally, the reliance of developed countries on China for the production of active ingredients has led to unexpected changes in China's pricing policies. These fluctuations are anticipated to adversely impact the overall growth of the market, creating challenges for manufacturers and affecting the supply chain dynamics in this sector.

Market Trends of the Global Active Ingredients Market

The Global Active Ingredients market is witnessing a significant trend towards the rising demand for multifunctional active ingredients across various sectors. In pharmaceuticals, these ingredients are increasingly valued for their ability to deliver therapeutic effects alongside enhanced bioavailability and extended release properties. In the personal care and cosmetics realm, consumers prefer products offering comprehensive benefits such as moisture retention, anti-aging effects, and UV protection within a single formulation. Similarly, in agriculture, multifunctional ingredients that combine antimicrobial properties with plant growth promotion enhance crop yield while minimizing application frequency. This trend is propelled by consumer preferences for simplicity and efficiency, cost reductions for manufacturers, and regulatory imperatives to streamline formulations.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis
• Customer & Buying Criteria Analysis

Global Active Ingredients Market Size by Form & CAGR (2025-2032)

• Market Overview
• Solid
• Liquid

Global Active Ingredients Market Size by Type & CAGR (2025-2032)

• Market Overview
• Moisturizing Agents
• Anti-ageing Agents
• UV Filters
• Exfoliating Agents
• Antimicrobial Agents
• Others.

Global Active Ingredients Market Size by Source & CAGR (2025-2032)

• Market Overview
• Natural
• Synthetic.

Global Active Ingredients Market Size by Distribution & CAGR (2025-2032)

• Market Overview
• Online
• Offline.

Global Active Ingredients Market Size by End-Use Industry & CAGR (2025-2032)

• Market Overview
• Personal Care & Cosmetics
  • Hair Care
  • Skin Care
  • Others
• Pharmaceutical
  • Tablets
  • Creams
  • Others
• Agriculture
  • Insecticides
  • Herbicides
  • Others
• Others

Global Active Ingredients Market Size & CAGR (2025-2032)

• North America (Form, Type, Source, Distribution, End-Use Industry)
  • US
  • Canada
• Europe (Form, Type, Source, Distribution, End-Use Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Form, Type, Source, Distribution, End-Use Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Form, Type, Source, Distribution, End-Use Industry)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Form, Type, Source, Distribution, End-Use Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations